[Can measurement of CRP and BNP concentrations be helpful in predicting relapses and therapy of atrial fibrillation?].
On account of universality and steadily rising frequency of atrial fibrillation new diagnostic and therapeutic methods of that arrhythmia are being sought. This work informs about a predictive role of measurement of C-reactive protein (CRP) and brain natriuretic peptide (BNP)ry concentrations in atrial fibrillation. The presented review of current research in the field of the above mentioned subject shows that high values of CRP quite tightly correlate with the risk of occurrence or relapse of that arrhythmia. Therapy effectiveness of atrial fibrillation is also lower in case of patients with high CRP concentration. Measurement of BNP is currently used, above all, in the diagnosis of heart failure. The work presents the arguments which can justify the usage of measurement of that hormone at above all prognostic proceedings in case of patients with various forms of atrial fibrillation.